2 legendary ASX large-cap shares trading on hard-to-ignore valuations

These large stocks look good value to me.

| More on:
A woman stands on a huge oversized wooden park bench with her arms outstretched towards the mountainous horizon in the distance.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX large-cap shares can be great investments due to their strong position in their industry and ability to deliver large profits.

With the S&P/ASX 200 Index (ASX: XJO) regularly hitting new all-time highs, it may be difficult to find investments that seem attractively priced.

But, there are a few areas of the market that look appealing.

I'm going to discuss two ASX large-cap shares that have seen their share prices decline over the past year, but their futures look promising.

Sonic Healthcare Ltd (ASX: SHL)

Sonic is a large, global pathology business with a presence in countries such as Australia, the USA, Germany, the UK, Switzerland and so on.

Over the past year, Sonic Healthcare's share price has fallen by 12%, compared to a 12% rise for the ASX 200.

It's understandable why the company has fallen due to a few factors, including inflation of costs and the loss of COVID-19 testing revenue.

But, I believe there are a number of positives that can help the company over the long-term. I'll mention a few of them now.

Sonic has made several acquisitions in Europe, particularly in Switzerland and Germany, to enhance its scale and presence in those regions. Sonic is currently working on unlocking synergies.

The ASX large-cap share has made equity investments in AI businesses, with those AI services potentially capable of improving Sonic's service and efficiencies.  

The last thing I'll point to is the ongoing solid organic base business revenue growth – in FY24 the growth rate was 6%.

According to the estimates on Commsec, the Sonic Healthcare share price is valued at under 22x FY26's estimated earnings with a forecast dividend yield of 4% (excluding franking credits).

Rio Tinto Ltd (ASX: RIO)

ASX iron ore shares can be opportunities when there is a significant weakness regarding the iron ore price. In 2024 to date, the Rio Tinto share price is down close to 20%.

Commodities can be cyclical opportunities if we buy when prices are low (and possibly sell when prices are higher).

There is no financial rule to say when the next rebound of the iron ore price will be, or by how much the price will rise.

However, there are some optimistic signs of a potential turnaround with President Xi Jinping urging China to strive to "achieve its annual economic and social development goals and tasks", raising market hopes for further stimulus, according to Trading Economics. It's also possible that China may soon cut interest rates for trillions of dollars of mortgages.

I'm also attracted to Rio Tinto's efforts to grow its copper exposure, which could be one of the most important commodities in the coming years because of its usage in things like electric vehicles and renewable energy.

The ASX large-cap share is valued at 10x FY26's estimated earnings with a possible fully franked dividend yield of 5.7% in FY26.

Motley Fool contributor Tristan Harrison has positions in Sonic Healthcare. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A happy older couple relax in a hammock together as they think about enjoying life with a passive income stream.
Blue Chip Shares

Buy these quality ASX blue chip shares for a passive income boost

Analysts think these blue chips could be great options for investors searching for passive income.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

3 excellent ASX 200 blue chip shares to buy in 2025

Analysts have good things to say about these blue chips.

Read more »

A fit man flexes his muscles, indicating a positive share price movement on the ASX market
Blue Chip Shares

3 strong ASX 200 blue chip stocks to buy with $2,000 in December

These blue chips have been given the thumbs up from analysts.

Read more »

A share market analyst looks at his computer screen in front of him showing ASX share price movements
Blue Chip Shares

Analysts name 3 strong blue chip ASX 200 shares to buy in December

Let's see which blue chips are bring tipped as buys by analysts right now.

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Blue Chip Shares

Buy these 3 high-quality ASX 200 blue chip shares in December

Analysts think these high-quality shares are buys right now. Let's see what they are saying.

Read more »

Two people comparing and analysing material.
Blue Chip Shares

Are Woodside or CBA shares a better buy?

Here’s how I’d compare these two major ASX blue chips.

Read more »

A group of young people lined up on a wall are happy looking at their laptops and devices as they invest in the latest trendy stock.
Blue Chip Shares

Why these ASX 200 blue chip shares could generate big returns

Brokers think these shares are could be dirt cheap at current levels.

Read more »

Man sits smiling at a computer showing graphs
Blue Chip Shares

3 ASX shares Australians can buy and hold for the next decade

Analysts think these high quality stocks could be in the buy zone right now.

Read more »